Evaluating the Global Educational Format Through More STEM Incorporation

For years now, a lot of discussion surrounding the STEM field has mostly focused on the lack of students pursuing the academic fields of science, technology, engineering, and mathematics. Although the shortage remains true, there’s also been a lot of work done to improve the numbers, according to the Bureau of Labor Statistics. In an episode of DisruptED, hosts Ron J Stefanski and Dr. Caesar Mickenstalked to two Croatian nationals dedicated to changing the current landscape of what education looks like, the gaps that exist, and how they are emphasizing STEM. Guests Marin Troselj, the CEO of STEMI, and Slobodan Velikic, a Chief Business Officer and Partner with STEMI, talked about their platform’s mission and their thoughts and solutions to what needs reorganizing.

Mickens stated that STEM numbers are concerning and there needs to be some kind of reinvigoration of the field to get the youth more readily interested and involved. While the U.S. once was No. 1 in STEM graduates, they are seeing lower numbers, and they are not alone. Globally, there’s been a drop in STEM graduates and professionals, said Mickens. But getting students to seek out STEM isn’t the only issue; it starts with going up against an increasingly outdated structure and teaching methods.

“In my opinion education around the world is going in the wrong direction,” said Troselj. “We are teaching kids to be experts in tests and not how to build meaningful stuff. We teach kids that the right answer is always in textbooks and don’t prepare them for the real world.”

Troselj stated that much of education was built to support the educational needs to produce a workforce for factories. Despite it evolving since, it still maintained its industrial roots.

With STEMI, Troselj and Slobodan Velikic are reshaping that landscape by making the testing and textbooks schools take a backseat. But more so, by turning education into something students can use outside of schools to solve real-life issues in their communities.

More Stories Like This:

How Technology and Education are Vital Cycle Breakers of Social Inequality

How Can Schools Help Ensure the Current Economic Recovery is Sustained and Inclusive

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More